img

Global H1N1 Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global H1N1 Vaccines Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
H1N1 Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global H1N1 Vaccines market is projected to reach US$ 5708.3 million in 2034, increasing from US$ 4576.4 million in 2022, with the CAGR of 3.2% during the period of 2024 to 2034. Demand from Influenza and Meningococcal are the major drivers for the industry.
The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor for acquiring H1N1 influenza. Moreover, increased research in the field of vaccine technologies and significant government support are driving this market. However, lack of awareness and absence of experienced medical professionals are restraining the growth of H1N1 vaccines market. Furthermore, high capital requirement and stringent regulations are also hindering the growth of the global H1N1 vaccination market.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global H1N1 Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Abbott
Baxter International
Sanofi
GSK
Pfizer
Mitsubishi Tanabe Pharma
Hualan Biological Engineering
Cipla
Merck
Sinovac Biotech
Segment by Type
Intramuscular Vaccines
Intranasal Vaccines
Intradermal Vaccines

Segment by Application


Influenza
Meningococcal
Cervical Cancer
Pneumococcal
Hepatitis
Measles
Mumps
Rubella
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the H1N1 Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of H1N1 Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the H1N1 Vaccines industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of H1N1 Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, H1N1 Vaccines introduction, etc. H1N1 Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of H1N1 Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 H1N1 Vaccines Market Overview
1.1 H1N1 Vaccines Product Overview
1.2 H1N1 Vaccines Market Segment by Type
1.2.1 Intramuscular Vaccines
1.2.2 Intranasal Vaccines
1.2.3 Intradermal Vaccines
1.3 Global H1N1 Vaccines Market Size by Type
1.3.1 Global H1N1 Vaccines Market Size Overview by Type (2024-2034)
1.3.2 Global H1N1 Vaccines Historic Market Size Review by Type (2024-2024)
1.3.3 Global H1N1 Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America H1N1 Vaccines Sales Breakdown by Type (2024-2024)
1.4.2 Europe H1N1 Vaccines Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific H1N1 Vaccines Sales Breakdown by Type (2024-2024)
1.4.4 Latin America H1N1 Vaccines Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa H1N1 Vaccines Sales Breakdown by Type (2024-2024)
2 Global H1N1 Vaccines Market Competition by Company
2.1 Global Top Players by H1N1 Vaccines Sales (2024-2024)
2.2 Global Top Players by H1N1 Vaccines Revenue (2024-2024)
2.3 Global Top Players by H1N1 Vaccines Price (2024-2024)
2.4 Global Top Manufacturers H1N1 Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 H1N1 Vaccines Market Competitive Situation and Trends
2.5.1 H1N1 Vaccines Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by H1N1 Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in H1N1 Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into H1N1 Vaccines Market
2.8 Key Manufacturers H1N1 Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 H1N1 Vaccines Status and Outlook by Region
3.1 Global H1N1 Vaccines Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global H1N1 Vaccines Historic Market Size by Region
3.2.1 Global H1N1 Vaccines Sales in Volume by Region (2024-2024)
3.2.2 Global H1N1 Vaccines Sales in Value by Region (2024-2024)
3.2.3 Global H1N1 Vaccines Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global H1N1 Vaccines Forecasted Market Size by Region
3.3.1 Global H1N1 Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global H1N1 Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global H1N1 Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global H1N1 Vaccines by Application
4.1 H1N1 Vaccines Market Segment by Application
4.1.1 Influenza
4.1.2 Meningococcal
4.1.3 Cervical Cancer
4.1.4 Pneumococcal
4.1.5 Hepatitis
4.1.6 Measles
4.1.7 Mumps
4.1.8 Rubella
4.1.9 Others
4.2 Global H1N1 Vaccines Market Size by Application
4.2.1 Global H1N1 Vaccines Market Size Overview by Application (2024-2034)
4.2.2 Global H1N1 Vaccines Historic Market Size Review by Application (2024-2024)
4.2.3 Global H1N1 Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America H1N1 Vaccines Sales Breakdown by Application (2024-2024)
4.3.2 Europe H1N1 Vaccines Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific H1N1 Vaccines Sales Breakdown by Application (2024-2024)
4.3.4 Latin America H1N1 Vaccines Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa H1N1 Vaccines Sales Breakdown by Application (2024-2024)
5 North America H1N1 Vaccines by Country
5.1 North America H1N1 Vaccines Historic Market Size by Country
5.1.1 North America H1N1 Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America H1N1 Vaccines Sales in Volume by Country (2024-2024)
5.1.3 North America H1N1 Vaccines Sales in Value by Country (2024-2024)
5.2 North America H1N1 Vaccines Forecasted Market Size by Country
5.2.1 North America H1N1 Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America H1N1 Vaccines Sales in Value by Country (2024-2034)
6 Europe H1N1 Vaccines by Country
6.1 Europe H1N1 Vaccines Historic Market Size by Country
6.1.1 Europe H1N1 Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe H1N1 Vaccines Sales in Volume by Country (2024-2024)
6.1.3 Europe H1N1 Vaccines Sales in Value by Country (2024-2024)
6.2 Europe H1N1 Vaccines Forecasted Market Size by Country
6.2.1 Europe H1N1 Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe H1N1 Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific H1N1 Vaccines by Region
7.1 Asia-Pacific H1N1 Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific H1N1 Vaccines Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific H1N1 Vaccines Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific H1N1 Vaccines Sales in Value by Region (2024-2024)
7.2 Asia-Pacific H1N1 Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific H1N1 Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific H1N1 Vaccines Sales in Value by Region (2024-2034)
8 Latin America H1N1 Vaccines by Country
8.1 Latin America H1N1 Vaccines Historic Market Size by Country
8.1.1 Latin America H1N1 Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America H1N1 Vaccines Sales in Volume by Country (2024-2024)
8.1.3 Latin America H1N1 Vaccines Sales in Value by Country (2024-2024)
8.2 Latin America H1N1 Vaccines Forecasted Market Size by Country
8.2.1 Latin America H1N1 Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America H1N1 Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa H1N1 Vaccines by Country
9.1 Middle East and Africa H1N1 Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa H1N1 Vaccines Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa H1N1 Vaccines Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa H1N1 Vaccines Sales in Value by Country (2024-2024)
9.2 Middle East and Africa H1N1 Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa H1N1 Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa H1N1 Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott H1N1 Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Abbott H1N1 Vaccines Products Offered
10.1.5 Abbott Recent Development
10.2 Baxter International
10.2.1 Baxter International Company Information
10.2.2 Baxter International Introduction and Business Overview
10.2.3 Baxter International H1N1 Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Baxter International H1N1 Vaccines Products Offered
10.2.5 Baxter International Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi H1N1 Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Sanofi H1N1 Vaccines Products Offered
10.3.5 Sanofi Recent Development
10.4 GSK
10.4.1 GSK Company Information
10.4.2 GSK Introduction and Business Overview
10.4.3 GSK H1N1 Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.4.4 GSK H1N1 Vaccines Products Offered
10.4.5 GSK Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer H1N1 Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Pfizer H1N1 Vaccines Products Offered
10.5.5 Pfizer Recent Development
10.6 Mitsubishi Tanabe Pharma
10.6.1 Mitsubishi Tanabe Pharma Company Information
10.6.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Products Offered
10.6.5 Mitsubishi Tanabe Pharma Recent Development
10.7 Hualan Biological Engineering
10.7.1 Hualan Biological Engineering Company Information
10.7.2 Hualan Biological Engineering Introduction and Business Overview
10.7.3 Hualan Biological Engineering H1N1 Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Hualan Biological Engineering H1N1 Vaccines Products Offered
10.7.5 Hualan Biological Engineering Recent Development
10.8 Cipla
10.8.1 Cipla Company Information
10.8.2 Cipla Introduction and Business Overview
10.8.3 Cipla H1N1 Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Cipla H1N1 Vaccines Products Offered
10.8.5 Cipla Recent Development
10.9 Merck
10.9.1 Merck Company Information
10.9.2 Merck Introduction and Business Overview
10.9.3 Merck H1N1 Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Merck H1N1 Vaccines Products Offered
10.9.5 Merck Recent Development
10.10 Sinovac Biotech
10.10.1 Sinovac Biotech Company Information
10.10.2 Sinovac Biotech Introduction and Business Overview
10.10.3 Sinovac Biotech H1N1 Vaccines Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Sinovac Biotech H1N1 Vaccines Products Offered
10.10.5 Sinovac Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 H1N1 Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 H1N1 Vaccines Industrial Chain Analysis
11.4 H1N1 Vaccines Market Dynamics
11.4.1 H1N1 Vaccines Industry Trends
11.4.2 H1N1 Vaccines Market Drivers
11.4.3 H1N1 Vaccines Market Challenges
11.4.4 H1N1 Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 H1N1 Vaccines Distributors
12.3 H1N1 Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Intramuscular Vaccines
Table 2. Major Company of Intranasal Vaccines
Table 3. Major Company of Intradermal Vaccines
Table 4. Global H1N1 Vaccines Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global H1N1 Vaccines Sales by Type (2024-2024) & (K Units)
Table 6. Global H1N1 Vaccines Sales Market Share in Volume by Type (2024-2024)
Table 7. Global H1N1 Vaccines Sales by Type (2024-2024) & (US& Million)
Table 8. Global H1N1 Vaccines Market Share in Value by Type (2024-2024)
Table 9. Global H1N1 Vaccines Price by Type (2024-2024) & (USD/Unit)
Table 10. Global H1N1 Vaccines Sales by Type (2024-2034) & (K Units)
Table 11. Global H1N1 Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 12. Global H1N1 Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 13. Global H1N1 Vaccines Sales Market Share in Value by Type (2024-2034)
Table 14. Global H1N1 Vaccines Price by Type (2024-2034) & (USD/Unit)
Table 15. North America H1N1 Vaccines Sales by Type (2024-2024) & (K Units)
Table 16. North America H1N1 Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe H1N1 Vaccines Sales (K Units) by Type (2024-2024)
Table 18. Europe H1N1 Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific H1N1 Vaccines Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific H1N1 Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America H1N1 Vaccines Sales (K Units) by Type (2024-2024)
Table 22. Latin America H1N1 Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa H1N1 Vaccines Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa H1N1 Vaccines Sales by Type (2024-2024) & (US$ Million)
Table 25. Global H1N1 Vaccines Sales by Company (2024-2024) & (K Units)
Table 26. Global H1N1 Vaccines Sales Share by Company (2024-2024)
Table 27. Global H1N1 Vaccines Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global H1N1 Vaccines Revenue Share by Company (2024-2024)
Table 29. Global Market H1N1 Vaccines Price by Company (2024-2024) & (USD/Unit)
Table 30. Global H1N1 Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global H1N1 Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in H1N1 Vaccines as of 2022)
Table 33. Date of Key Manufacturers Enter into H1N1 Vaccines Market
Table 34. Key Manufacturers H1N1 Vaccines Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global H1N1 Vaccines Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global H1N1 Vaccines Sales by Region (2024-2024) & (K Units)
Table 38. Global H1N1 Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 39. Global H1N1 Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 40. Global H1N1 Vaccines Sales Market Share in Value by Region (2024-2024)
Table 41. Global H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 42. Global H1N1 Vaccines Sales by Region (2024-2034) & (K Units)
Table 43. Global H1N1 Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 44. Global H1N1 Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 45. Global H1N1 Vaccines Sales Market Share in Value by Region (2024-2034)
Table 46. Global H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global H1N1 Vaccines Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global H1N1 Vaccines Sales by Application (2024-2024) & (K Units)
Table 49. Global H1N1 Vaccines Sales Market Share in Volume by Application (2024-2024)
Table 50. Global H1N1 Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 51. Global H1N1 Vaccines Sales Market Share in Value by Application (2024-2024)
Table 52. Global H1N1 Vaccines Price by Application (2024-2024) & (USD/Unit)
Table 53. Global H1N1 Vaccines Sales by Application (2024-2034) & (K Units)
Table 54. Global H1N1 Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 55. Global H1N1 Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 56. Global H1N1 Vaccines Sales Market Share in Value by Application (2024-2034)
Table 57. Global H1N1 Vaccines Price by Application (2024-2034) & (USD/Unit)
Table 58. North America H1N1 Vaccines Sales by Application (2024-2024) (K Units)
Table 59. North America H1N1 Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe H1N1 Vaccines Sales by Application (2024-2024) (K Units)
Table 61. Europe H1N1 Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific H1N1 Vaccines Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific H1N1 Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America H1N1 Vaccines Sales by Application (2024-2024) (K Units)
Table 65. Latin America H1N1 Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa H1N1 Vaccines Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa H1N1 Vaccines Sales by Application (2024-2024) & (US$ Million)
Table 68. North America H1N1 Vaccines Sales by Country (2024-2024) & (K Units)
Table 69. North America H1N1 Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 70. North America H1N1 Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 71. North America H1N1 Vaccines Sales Market Share in Value by Country (2024-2024)
Table 72. North America H1N1 Vaccines Sales by Country (2024-2034) & (K Units)
Table 73. North America H1N1 Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 74. North America H1N1 Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 75. North America H1N1 Vaccines Sales Market Share in Value by Country (2024-2034)
Table 76. Europe H1N1 Vaccines Sales by Country (2024-2024) & (K Units)
Table 77. Europe H1N1 Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe H1N1 Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe H1N1 Vaccines Sales Market Share in Value by Country (2024-2024)
Table 80. Europe H1N1 Vaccines Sales by Country (2024-2034) & (K Units)
Table 81. Europe H1N1 Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe H1N1 Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe H1N1 Vaccines Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific H1N1 Vaccines Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific H1N1 Vaccines Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific H1N1 Vaccines Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific H1N1 Vaccines Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific H1N1 Vaccines Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific H1N1 Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific H1N1 Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific H1N1 Vaccines Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America H1N1 Vaccines Sales by Country (2024-2024) & (K Units)
Table 93. Latin America H1N1 Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America H1N1 Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America H1N1 Vaccines Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America H1N1 Vaccines Sales by Country (2024-2034) & (K Units)
Table 97. Latin America H1N1 Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America H1N1 Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America H1N1 Vaccines Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa H1N1 Vaccines Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa H1N1 Vaccines Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa H1N1 Vaccines Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa H1N1 Vaccines Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa H1N1 Vaccines Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa H1N1 Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa H1N1 Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa H1N1 Vaccines Sales Market Share in Value by Country (2024-2034)
Table 108. Abbott Company Information
Table 109. Abbott Introduction and Business Overview
Table 110. Abbott H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 111. Abbott H1N1 Vaccines Product
Table 112. Abbott Recent Development
Table 113. Baxter International Company Information
Table 114. Baxter International Introduction and Business Overview
Table 115. Baxter International H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 116. Baxter International H1N1 Vaccines Product
Table 117. Baxter International Recent Development
Table 118. Sanofi Company Information
Table 119. Sanofi Introduction and Business Overview
Table 120. Sanofi H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 121. Sanofi H1N1 Vaccines Product
Table 122. Sanofi Recent Development
Table 123. GSK Company Information
Table 124. GSK Introduction and Business Overview
Table 125. GSK H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 126. GSK H1N1 Vaccines Product
Table 127. GSK Recent Development
Table 128. Pfizer Company Information
Table 129. Pfizer Introduction and Business Overview
Table 130. Pfizer H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 131. Pfizer H1N1 Vaccines Product
Table 132. Pfizer Recent Development
Table 133. Mitsubishi Tanabe Pharma Company Information
Table 134. Mitsubishi Tanabe Pharma Introduction and Business Overview
Table 135. Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 136. Mitsubishi Tanabe Pharma H1N1 Vaccines Product
Table 137. Mitsubishi Tanabe Pharma Recent Development
Table 138. Hualan Biological Engineering Company Information
Table 139. Hualan Biological Engineering Introduction and Business Overview
Table 140. Hualan Biological Engineering H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 141. Hualan Biological Engineering H1N1 Vaccines Product
Table 142. Hualan Biological Engineering Recent Development
Table 143. Cipla Company Information
Table 144. Cipla Introduction and Business Overview
Table 145. Cipla H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 146. Cipla H1N1 Vaccines Product
Table 147. Cipla Recent Development
Table 148. Merck Company Information
Table 149. Merck Introduction and Business Overview
Table 150. Merck H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 151. Merck H1N1 Vaccines Product
Table 152. Merck Recent Development
Table 153. Sinovac Biotech Company Information
Table 154. Sinovac Biotech Introduction and Business Overview
Table 155. Sinovac Biotech H1N1 Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 156. Sinovac Biotech H1N1 Vaccines Product
Table 157. Sinovac Biotech Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. H1N1 Vaccines Market Trends
Table 161. H1N1 Vaccines Market Drivers
Table 162. H1N1 Vaccines Market Challenges
Table 163. H1N1 Vaccines Market Restraints
Table 164. H1N1 Vaccines Distributors List
Table 165. H1N1 Vaccines Downstream Customers
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. H1N1 Vaccines Product Picture
Figure 2. Global H1N1 Vaccines Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global H1N1 Vaccines Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global H1N1 Vaccines Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Intramuscular Vaccines
Figure 6. Global Intramuscular Vaccines Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Intranasal Vaccines
Figure 8. Global Intranasal Vaccines Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Intradermal Vaccines
Figure 10. Global Intradermal Vaccines Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global H1N1 Vaccines Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global H1N1 Vaccines Sales Market Share by Type in 2022 & 2034
Figure 13. North America H1N1 Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. North America H1N1 Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Europe H1N1 Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Europe H1N1 Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific H1N1 Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific H1N1 Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Latin America H1N1 Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Latin America H1N1 Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa H1N1 Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa H1N1 Vaccines Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by H1N1 Vaccines Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by H1N1 Vaccines Revenue in 2022
Figure 25. H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Influenza
Figure 27. Global Influenza Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Meningococcal
Figure 29. Global Meningococcal Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Cervical Cancer
Figure 31. Global Cervical Cancer Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Pneumococcal
Figure 33. Global Pneumococcal Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Hepatitis
Figure 35. Global Hepatitis Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Measles
Figure 37. Global Measles Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Product Picture of Mumps
Figure 39. Global Mumps Sales YoY Growth (2024-2034) & (K Units)
Figure 40. Product Picture of Rubella
Figure 41. Global Rubella Sales YoY Growth (2024-2034) & (K Units)
Figure 42. Product Picture of Others
Figure 43. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 44. Global H1N1 Vaccines Sales by Application (2024-2034) & (US$ Million)
Figure 45. Global H1N1 Vaccines Sales Market Share by Application in 2022 & 2034
Figure 46. North America H1N1 Vaccines Sales Market Share in Volume by Application in 2022
Figure 47. North America H1N1 Vaccines Sales Market Share in Value by Application in 2022
Figure 48. Europe H1N1 Vaccines Sales Market Share in Volume by Application in 2022
Figure 49. Europe H1N1 Vaccines Sales Market Share in Value by Application in 2022
Figure 50. Asia-Pacific H1N1 Vaccines Sales Market Share in Volume by Application in 2022
Figure 51. Asia-Pacific H1N1 Vaccines Sales Market Share in Value by Application in 2022
Figure 52. Latin America H1N1 Vaccines Sales Market Share in Volume by Application in 2022
Figure 53. Latin America H1N1 Vaccines Sales Market Share in Value by Application in 2022
Figure 54. Middle East and Africa H1N1 Vaccines Sales Market Share in Value by Application in 2022
Figure 55. Key Raw Materials Price
Figure 56. H1N1 Vaccines Manufacturing Cost Structure
Figure 57. H1N1 Vaccines Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed